
Early results from COVID-19 drug trial boost optimism
Dr. Anthony Fauci, the top United States infectious disease official, has expressed confidence in biotechnology company Gilead Sciences Inc.’s experimental antiviral drug remdesivir being the “standard of care” for COVID-19.
This comes after preliminary results from a key clinical trial were shown on Wednesday, April 29 that patients given